17min chapter

The Fellow on Call: The Heme/Onc Podcast cover image

Episode 097: Treatment of Relapsed/Refractory CLL

The Fellow on Call: The Heme/Onc Podcast

CHAPTER

Navigating Relapsed CLL Treatment Options

This chapter examines treatment strategies for relapsed or refractory chronic lymphocytic leukemia (CLL), focusing on fixed-duration and indefinite therapies involving key medications like obinutuzumab and venetoclax. It follows a patient case to illustrate the need for careful management and evaluation amidst complications such as tumor lysis syndrome and new anemia. The discussion further emphasizes the evolving landscape of second-line therapies, including the role of BTK inhibitors and the potential for allogeneic transplants.

00:00

Get the Snipd
podcast app

Unlock the knowledge in podcasts with the podcast player of the future.
App store bannerPlay store banner

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode

Save any
moment

Hear something you like? Tap your headphones to save it with AI-generated key takeaways

Share
& Export

Send highlights to Twitter, WhatsApp or export them to Notion, Readwise & more

AI-powered
podcast player

Listen to all your favourite podcasts with AI-powered features

Discover
highlights

Listen to the best highlights from the podcasts you love and dive into the full episode